Obstetrics & Gynaecology · Pelvic Inflammatory Disease and Genital Tuberculosis

A 25-year-old presents with 5 days of lower abdominal pain, cervical motion tenderness, and mucopurulent cervical discharge. Temperature 38.2°C, WBC 14,000/µL. Transvaginal ultrasound shows bilateral adnexal thickening but no abscess. Per CDC 2021 guidelines, which outpatient treatment regimen is appropriate for PID?

  • A Single-dose azithromycin 1g + doxycycline 100 mg BD for 14 days
  • B Ceftriaxone 500 mg IM single dose + doxycycline 100 mg BD for 14 days + metronidazole 500 mg BD for 14 days
  • C Amoxicillin-clavulanate 875 mg BD for 14 days + metronidazole 500 mg BD
  • D Ciprofloxacin 500 mg BD for 14 days + metronidazole 500 mg BD for 14 days
Correct answer: B. Ceftriaxone 500 mg IM single dose + doxycycline 100 mg BD for 14 days + metronidazole 500 mg BD for 14 days

Explanation

CDC 2021 STI Treatment Guidelines for outpatient PID management recommend: Ceftriaxone 500 mg IM single dose (1g if weight ≥ 150 kg) PLUS doxycycline 100 mg orally twice daily for 14 days WITH metronidazole 500 mg orally twice daily for 14 days. The ceftriaxone covers gonorrhoeal and other gram-negative organisms; doxycycline covers Chlamydia and other pathogens; metronidazole addresses anaerobes important in upper genital tract infection. Fluoroquinolones (ciprofloxacin) are no longer recommended due to high Neisseria gonorrhoeae resistance rates. Amoxicillin-clavulanate does not provide adequate anti-chlamydial coverage.

Reference: Shaw's Textbook of Gynaecology, 17th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Pelvic Inflammatory Disease and Genital Tuberculosis MCQs

See all Pelvic Inflammatory Disease and Genital Tuberculosis MCQs →